Myasthenia gravis after allogeneic bone marrow transplantation: A case report and literature review | Zendy

Yutaka Tsutsumi | Zendy; Takashi Kamiishi | Zendy; Ryo Kikuchi | Zendy; Shinichi Ito | Zendy; Satomi Matsuoka | Zendy; Takanori Teshima | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Myasthenia gravis after allogeneic bone marrow transplantation: A case report and literature review

Author(s) -

Yutaka Tsutsumi,

Takashi Kamiishi,

Ryo Kikuchi,

Shinichi Ito,

Satomi Matsuoka,

Takanori Teshima

Publication year - 2017

Publication title -

hematology/oncology and stem cell therapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.666

H-Index - 22

eISSN - 1658-3876

pISSN - 2589-0646

DOI - 10.1016/j.hemonc.2017.04.001

Subject(s) - medicine , myasthenia gravis , hematopoietic stem cell transplantation , myeloid leukemia , transplantation , disease , weakness , surgery , graft versus host disease , myeloid

A 52-year-old man with acute myeloid leukemia underwent allogeneic hematopoietic stem cell transplantation and developed extensive chronic graft-versus-host disease and myasthenia gravis (MG), which became involved with oculobulbar and proximal upper and lower limb weakness in 677days. In the literature, we identified 24 cases where MG developed after allo-SCT. Graft-versus-host disease development and male recipients of female donors might be prone to the development of posttransplant MG (odds ratio, 3.75).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research